Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesetaxel in Metastatic Breast Cancer
NCT01221870Phase 2Unknown
- Sponsor
- Genta Incorporated
- Start
- Nov 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tesetaxel in breast cancer, sponsored by Genta Incorporated. Status: unknown.
02
Drugs
tesetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01221870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01221870.